← Back to headlines
FDA Approves Landmark Drug to Improve Pancreatic Cancer Survival
The U.S. Food and Drug Administration has granted approval for a groundbreaking new medication designed to significantly extend survival rates for patients with pancreatic cancer.
29 Aug, 15:56 — 29 Aug, 16:47
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
taipei-times
Center
Right1
Right (1)
Ahram Online
Far R
Geographic diversity— 2 regions9/34
Taiwan1Egypt1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
taipei-timesMostly Factual2d ago
FDA orders recall of heart drug tablets over impurities
Read full article →Ahram OnlineMixed2d ago
FDA approves landmark pancreatic cancer drug that improves survival - Health - Life & Style - Ahram Online
FDA approves landmark pancreatic cancer drug that improves survival - Health - Life & Style Ahram Online
Read full article →Coverage Timeline
First report: Ahram Online · 29 Aug, 15:56|Full coverage: 2 · 51m|Window: 51m
Left-leaningCenterRight-leaning
